| Filed On | Filing |
|---|---|
| 06 Oct 2026 |
8-K: Other Events
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission. |
| 14 Sep 2026 |
8-K: Regulation FD Disclosure
On September 14, 2026, Kairos Pharma, Ltd., a Delaware corporation (the “Company”), issued a new investor presentation, which will be published on the Company’s website, www.kairospharma.com, and presented at the H.C. Wainwright 28th Ann... |
| 21 Aug 2026 | 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more |
| 12 Aug 2026 | 10-Q |
| 22 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 15 Jul 2026 | 8-K: Other Events |
| 30 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 04 Jun 2026 | 8-K: Other Events |
| 26 May 2026 | DEFA14A |
| 22 May 2026 | ARS |
| 22 May 2026 |
Proxy statement: annual meeting on June 29, 2026
say-on-pay vote |
| 18 May 2026 | 8-K: Other Events |
| 13 May 2026 | 10-Q |
| 11 May 2026 | PRE 14A |
| 01 Apr 2026 | 424B3 |
| 01 Apr 2026 | 424B3 |
| 31 Mar 2026 | 10-K |
| 02 Mar 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 26 Feb 2026 | 8-K: Other Events |
| 23 Jan 2026 | EFFECT |
Loading...
